Skip to main content
SpringerLink
Log in

Prostate Cancer: New Horizons in Research and Treatment

  • Book
  • © 2002

Overview

Editors:
  1. Michael L. Cher

    1. The Barbara Ann Karmanos Cancer Institute, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Avraham Raz

    1. Wayne State University School of Medicine, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Kenneth V. Honn

    1. Wayne State University School of Medicine, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Oncology (DION, volume 81)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (26 chapters)

  1. Front Matter

    Pages i-1
    Download chapter PDF

  2. Pathology of prostate cancer

    • Mingxin Che, David Grignon
    Pages 3-17

  3. Prostate cancer susceptibility genes: Many studies, many results, no answers

    • Nina N. Nupponen, John D. Carpten
    Pages 19-28

  4. Molecular profiling in prostate cancer

    • F. Feroze-Merzoug, M. S. Schober, Y. Q. Chen
    Pages 29-35

  5. Chromosomal deletions and tumor suppressor genes in prostate cancer

    • Jin-Tang Dong
    Pages 37-57

  6. Role of eicosanoids in prostate cancer progression

    • Daotai Nie, Mingxin Che, David Grignon, Keqin Tang, Kenneth V. Honn
    Pages 59-70

  7. Contribution of the androgen receptor to prostate cancer predisposition and progression

    • Grant Buchanan, Ryan A. Irvine, Gerhard A. Coetzee, Wayne D. Tilley
    Pages 71-87

  8. Regulation of apoptosis in prostate cancer

    • Sushma Gurumurthy, Krishna Murthi Vasudevan, Vivek M. Rangnekar
    Pages 89-107

  9. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis

    • Elieser Gorelik, Uri Galili, Avraham Raz
    Pages 109-141

  10. Metastasis suppression in prostate cancer

    • Erich B. Jaeger, Rajeev S. Samant, Carrie W. Rinker-Schaeffer
    Pages 143-150

  11. The urokinase-type plasminogen activator system in prostate cancer metastasis

    • Shijie Sheng
    Pages 151-160

  12. Angiogenesis in prostate cancer: Biology and therapeutic opportunities

    • Brian Nicholson, Greg Schaefer, Dan Theodorescu
    Pages 161-183

  13. Integrins and prostate cancer metastases

    • Mara Fornaro, Thomas Manes, Lucia R. Languino
    Pages 185-195

  14. Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone

    • Evan T. Keller, Jian Zhang, Carlton R. Cooper, Peter C. Smith, Laurie K. McCauley, Kenneth J. Pienta et al.
    Pages 197-213

  15. Signal transduction targets in androgen-independent prostate cancer

    • Jian Zhou, Jessica Scholes, Jer-Tsong Hsieh
    Pages 215-226

  16. The diet, prostate inflammation, and the development of prostate cancer

    • William G. Nelson, Theodore L. DeWeese, Angelo M. DeMarzo
    Pages 227-240

  17. Prostate cancer diagnosis, staging and survival

    • Vivek Narain, Michael L. Cher, David P. Wood Jr.
    Pages 241-251

  18. Surgery for prostate cancer: Rationale, technique and outcomes

    • Tracy M. Downs, Christopher J. Kane, Gary D. Grossfeld, Maxwell V. Meng, Peter R. Carroll
    Pages 253-268

  19. The future of cancer imaging

    • David A. Benaron
    Pages 269-302

  20. Antisense therapy: Current status in prostate cancer and other malignancies

    • Martin Gleave, Hideake Miyake, Uwe Zangemeister-Wittke, Burkhard Jansen
    Pages 303-316
Back to top

Keywords

About this book

In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an understanding of the cellular and molecular mechanisms of disease.
In creating this book, we aimed to cover a broad "bench to bedside" research spectrum ranging from: genetic, molecular and cellular analyses to epidemiological studies, refinements in local treatment strategies and new biologically based non-hormonal treatments for systemic disease.
Researchers and clinicians will find in this book a group of timely and clinically relevant chapters on prostate cancer research and treatment.

Editors and Affiliations

  • The Barbara Ann Karmanos Cancer Institute, Detroit, USA

    Michael L. Cher

  • Wayne State University School of Medicine, Detroit, USA

    Avraham Raz, Kenneth V. Honn

Bibliographic Information

  • Book Title: Prostate Cancer: New Horizons in Research and Treatment

  • Editors: Michael L. Cher, Avraham Raz, Kenneth V. Honn

  • Series Title: Developments in Oncology

  • DOI: https://doi.org/10.1007/b101860

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2002

  • Hardcover ISBN: 978-1-4020-7352-6Due: 31 December 2002

  • Softcover ISBN: 978-1-4757-8511-1Published: 23 October 2013

  • eBook ISBN: 978-0-306-48143-7Published: 11 April 2006

  • Edition Number: 1

  • Number of Pages: VI, 399

  • Number of Illustrations: 119 b/w illustrations, 30 illustrations in colour

  • Topics: Oncology, Pathology, Urology, Cancer Research

Publish with us

Policies and ethics

Back to top

Search

Navigation